Skip to main content
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2005 Jan;20(1):131–134. doi: 10.1007/BF02893058

Study of some common biochemical bone turnover markers in postmenopausal women

Ashuma Sachdeva 1,, Shashi Seth 1, Anju Huria Khosla 1, Sumit Sachdeva 1
PMCID: PMC3454147  PMID: 23105510

Abstract

Markers of bone formation in serum include total and bone specific alkaline phosphatase, osteocalcin and Type 1 collagen carboxy terminal extension peptide. Bone resorption can be assessed by measuring plasma tartarate resistant acid phosphtase and urinary excretion of collagen degradation products: hydroxyproline, hydroxylysine glycosides and more recently the pyridinium crosslinks and associated peptides. We compared the excretion of hydroxyproline in women of reproductive age group to those of menopausal age group and found a significant difference in the two age groups. Urinary hydroxyproline was found to be significantly raised in post menopausal women. Thus hydroxyproline maybe used as the earliest indicator in the prognostic assessment of postmenopausal women of their risk of developing osteoporosis and fracture.

Key Words: hydroxyproline, osteoporosis, postmenopausal women

Full Text

The Full Text of this article is available as a PDF (313.6 KB).

Bibliography

  • 1.Endres DB, Rude RK. Mineral and bone metabolism. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia: W.B. Saunders; 1998. pp. 1395–14. [Google Scholar]
  • 2.Calvo MS, Eyre DR, Gundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Endocrin Rev. 1996;17:333–68. doi: 10.1210/er.17.4.333. [DOI] [PubMed] [Google Scholar]
  • 3.Garnero P, Delmas PD. New developments in biochemical markers for osteoporosis. Calcif Tissue Int. 1996;59(Suppl 1):S2–S9. doi: 10.1007/s002239900168. [DOI] [PubMed] [Google Scholar]
  • 4.Krane SM, Holick MF. Metabolic bone disease. In: Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s Principles of Intermal Medicine. 13th ed. New York: McGraw Hill; 1994. pp. 2172–83. [Google Scholar]
  • 5.Carr BR, Bradshaw KD. Disorders of the Ovary and female reproductive tract. In: Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s Principles of Internal Medicine. 14th ed. New York: McGraw Hill; 1998. pp. 2097–115. [Google Scholar]
  • 6.Taylor AK, Leuken SA, Libanati C, Baylink DJ. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am. 1994;20:589–607. [PubMed] [Google Scholar]
  • 7.Demers LM. Clinical usefulness of markers of bone degradation and formation. Scand J Clin Lab Invest. 1997;57:12–20. doi: 10.3109/00365519709168304. [DOI] [PubMed] [Google Scholar]
  • 8.Doumas BT. Standards for total serum protein assays—A collaborative study. Clin Chem. 1975;21:1159–66. [PubMed] [Google Scholar]
  • 9.Doumas BT, Biggs HG. Estimation of alburmin in serum. Clin Chem. 1972;18:175–88. [Google Scholar]
  • 10.Connerty HV, Briggs AR. Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol. 1966;45:290–6. doi: 10.1093/ajcp/45.3.290. [DOI] [PubMed] [Google Scholar]
  • 11.Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem. 1925;66:375–400. [Google Scholar]
  • 12.Calcium . Phosphorous and Phosphatases. In: Varley H, editor. Practical Clinical Biochemistry. 4th ed. New Delhi: CBS; 1988. pp. 431–67. [Google Scholar]
  • 13.Mitoma C, Smith TE, Davidson JD, Udenfried S, Dalosta M, Sjoerdsma A. Improvements in methods for measuring hydroxyproline. J Lab Clin Med. 1959;53:970–6. [PubMed] [Google Scholar]
  • 14.Newman DJ, Price C. Renal function and nitrogen metabolites. In: Burtis CA, Ashwood ER, editors. Tietz Texbook of Clinical Chemistry. 3rd ed. Philadelphia: W.B. Saunders; 1998. pp. 1204–70. [Google Scholar]
  • 15.Kato T, Chen JT, Katase K, Hirai Y, Shiraki Y, Hasumi K, et al. Time course changes in bone metabolic markers after menopause—cross sectional study. Nippon Sanka Fujinka Gakkai Zasshi. 1995;47:43–8. [PubMed] [Google Scholar]
  • 16.Beck Jensen JE, Kollerup G, Sorensen HA, Pors Nielsen S, Sorensen OH. A single measurement of biochemical markers of bone turnover has limited utility in the individual person. Scand J Clin Lab Invest. 1997;57:351–9. doi: 10.3109/00365519709099408. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES